Global Patent Index - EP 3664832 B1

EP 3664832 B1 20231018 - TRUNCATED GUINEA PIG L-ASPARAGINASE VARIANTS AND METHODS OF USE

Title (en)

TRUNCATED GUINEA PIG L-ASPARAGINASE VARIANTS AND METHODS OF USE

Title (de)

VERKÜRZTE L-ASPARAGINASE-VARIANTEN VOM MEERSCHWEINCHEN UND VERFAHREN ZUR VERWENDUNG

Title (fr)

VARIANTES TRONQUÉES DE LA L-ASPARAGINASE DE COCHON D'INDE ET PROCÉDÉS D'UTILISATION

Publication

EP 3664832 B1 20231018 (EN)

Application

EP 18760167 A 20180810

Priority

  • US 201762544411 P 20170811
  • US 201762544396 P 20170811
  • US 2018046196 W 20180810

Abstract (en)

[origin: WO2019032952A1] Variant guinea pig L-asparaginases which are truncated and humanized are described as are fusion proteins containing the L-asparaginase and use of the L- asparaginases in the treatment of cancers such as acute lymphoblastic leukemia and acute myeloid leukemia.

IPC 8 full level

A61K 38/00 (2006.01); C12N 9/82 (2006.01)

CPC (source: EP US)

A61P 35/02 (2018.01 - US); C12N 9/82 (2013.01 - EP US); C12Y 305/01001 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US); C07K 2319/00 (2013.01 - EP)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2019032952 A1 20190214; WO 2019032952 A8 20190725; AU 2018313253 A1 20200227; AU 2018313253 B2 20240926; CA 3106549 A1 20190214; CN 111050784 A 20200421; CN 111050784 B 20240319; EP 3664832 A1 20200617; EP 3664832 B1 20231018; EP 3664832 C0 20231018; ES 2965372 T3 20240415; JP 2020530300 A 20201022; US 11578315 B2 20230214; US 2020239867 A1 20200730

DOCDB simple family (application)

US 2018046196 W 20180810; AU 2018313253 A 20180810; CA 3106549 A 20180810; CN 201880051871 A 20180810; EP 18760167 A 20180810; ES 18760167 T 20180810; JP 2020507589 A 20180810; US 201816637070 A 20180810